Pharmaceuticals, Biotechnology and Life Sciences
Altadena, CA, July 13, 2021 (GLOBE NEWSWIRE) — Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) (“Lixte” or the “Company”) noted that…
Positive Results from Phase 2 Presbyopia (VEGA-1) and Phase 3 Reversal of Mydriasis (MIRA-2) Studies to be Presented at 2021…
WOBURN, Mass., July 13, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it…
MELBOURNE, Australia, July 11, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce…
—Multiple data presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2021 highlight durability of effect…
New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn’s and Colitis Organisation (ECCO) virtual congress…
Multiple doses of PHA121 were well-tolerated and showed a favorable pharmacokinetic profile for prophylactic treatment of HAEZUG, Switzerland, July 10,…
– 95% complete response rate after single dose of CDX-0159 — Rapid, profound and durable responses offer patients opportunity for…
FARMINGTON HILLS, Mich., July 09, 2021 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), today announced that the Compensation Committee…
SOUTH ORANGE, NJ, July 09, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology…